E-LIB Suche - Ergebnisse für: Barnes, G.

1

Tislelizumab versus chemotherapy as second-line treatment f..:

Ajani, J. ; El Hajbi, F. ; Cunningham, D....
ESMO Open. 9 (2024) 1 - p. 102202 , 2024

Link: https://doi.org/10.1016/..

2

PB0503 Patient Perspectives on Barriers and Facilitators to..:

Wilson, A. ; Jones, A. ; Slager, S....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 101887 , 2023

Link: https://doi.org/10.1016/..

3

PB0015 Potential of Racial Bias in Atrial Fibrillation Pati..:

Kaatz, S. ; Ellsworth, S. ; Ryan, N....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 100696 , 2023

Link: https://doi.org/10.1016/..

4

Zanubrutinib versus ibrutinib in relapsed/refractory chroni..:

Eichhorst, B. ; Lamanna, N. ; O'Brien, S. M....
Hematological Oncology. 41 (2023) S2 - p. 463-464 , 2023

Link: https://doi.org/10.1002/..

5

Machine Learning Differentiation of Autism Spectrum Sub-Cla..:

Thapa, R ; Garikipati, A ; Ciobanu, M...
Journal of Autism and Developmental Disorders. , 2023

Link: https://doi.org/10.1007/..

6

318 Implementation and Evaluation of a Single Center, Multi..:

O'Hare, C. ; Gavrila, V. ; Joyce, E....
Annals of Emergency Medicine. 82 (2023) 4 - p. S139 , 2023

Link: https://doi.org/10.1016/..

7

PB0014 Do Antiphospholipid Antibodies Inform the Choice of ..:

Bikdeli, B. ; Bejjani, A. ; Khairani, C....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 100697 , 2023

Link: https://doi.org/10.1016/..

8

The effects of tislelizumab plus chemotherapy as first-line..:

Wang, J ; Yu, X ; Barnes, G...
Cancer Treatment and Research Communications. 30 (2022) - p. 100501 , 2022

Link: https://doi.org/10.1016/..

9

POSA306 Recommended Approaches for Analyzing Clinical Outco..:

Stull, D ; Griffiths, P ; Reaney, M.
Value in Health. 25 (2022) 1 - p. S199 , 2022

Link: https://doi.org/10.1016/..

10

P663: HEALTH-RELATED QUALITY OF LIFE OUTCOMES ASSOCIATED WI..:

Hillmen, P. ; Brown, J. ; Lamanna, N....
HemaSphere. 6 (2022) - p. 561-562 , 2022

Link: https://doi.org/10.1097/..

11

P662: PATIENT-REPORTED OUTCOMES FROM A PHASE 3 RANDOMIZED S..:

Ghia, P. ; Barnes, G. ; Yang, K....
HemaSphere. 6 (2022) - p. 560-561 , 2022

Link: https://doi.org/10.1097/..

12

P5 Anchor-Based Thresholds for Meaningful within-Patient Ch..:

Iaconangelo, C. ; McManus, S. ; Serrano, D....
Value in Health. 25 (2022) 7 - p. S288 , 2022

Link: https://doi.org/10.1016/..

13

Tislelizumab versus chemotherapy as second-line treatment o..:

Van Cutsem, E. ; Kato, K. ; Ajani, J....
ESMO Open. 7 (2022) 4 - p. 100517 , 2022

Link: https://doi.org/10.1016/..

14

PCN192 Psychometric Validation of the EORTC QLQ-HCC18 in Pa..:

Serrano, D. ; Barnes, G. ; Podger, L...
Value in Health. 24 (2021) - p. S55 , 2021

Link: https://doi.org/10.1016/..

15

The Correlation Between Changes in Cardiac Biomarkers and C..:

Shepherd, A.F. ; Yu, A. ; Margaret, C.A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e450-e451 , 2021

Link: https://doi.org/10.1016/..